DBV Technologies raises $30 million through ADS sale on Nasdaq
PositiveFinancial Markets

DBV Technologies has successfully raised $30 million through the sale of American Depositary Shares (ADS) on Nasdaq. This funding is significant as it will bolster the company's efforts in developing innovative treatments in the biotech sector, particularly for food allergies. The successful capital raise reflects investor confidence in DBV's potential and could accelerate the timeline for bringing new therapies to market, ultimately benefiting patients in need.
— Curated by the World Pulse Now AI Editorial System